Reconciled Farm Bill Includes Provisions Lifting Federal Hemp Ban

Generic 30 November 2018 | 0 Comments

Washington, DC: House and Senate lawmakers have agreed to a reconciled version of H.R. 2: The Agriculture Improvement Act of 2018 (aka the 2018 Farm Bill), which includes provisions lifting the federal prohibition of industrial hemp. “For the first time in nearly a hundred years, commercial hemp production will no longer be federally prohibited in the […]

Tagged in , , ,

Indiana NORML: Midterm Elections Shakeup State Legislature

Generic 16 November 2018 | 0 Comments

On Tuesday, November 6th, Indiana voters took their final opportunity to vote in the 2018 midterm election. While Indiana did not have the opportunity to vote directly on cannabis propositions as in other states, there were numerous candidates on the ballot supportive of reforming our cannabis laws. Many of them did not win their races, […]

Tagged in , , ,

Cannabis pain relief without the ‘high’

Did you know that? 26 October 2018 | 0 Comments

In the wake of cannabis legalization, a team of scientists have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol (CBD) for safe pain relief without the typical ‘high’ or euphoria produced by the THC.

Tagged in ,

New Gallup Poll Finds 66 Percent Of Americans Want Marijuana Legal

Generic 23 October 2018 | 0 Comments

Sixty-six percent of US adults believe that “the use of marijuana should be made legal,” according to national survey data compiled by the Gallup. The percentage is the highest ever reported by Gallup, which has been tracking Americans’ views on the subject of marijuana legalization since 1969. Support was strongest among Millennials (78 percent), Democrats (75 percent), […]

Tagged in , , ,

DEA Reclassifies Plant-Derived Marijuana Medicine To Schedule V

Generic 28 September 2018 | 0 Comments

Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), has been reclassified today by the US Drug Enforcement Administration to Schedule V — the lowest restriction classification available under federal law. The US Food and Drug Administration had previously approved the product in June for the explicit treatment of two rare forms […]

Tagged in , , ,